Latest News about Eli Lilly and Co

Recent news which mentions Eli Lilly and Co

< Previous 1 2 3 4 5 6 7 8 9

...

Iran tensions, Palantir earnings, Musk's SEC settlement and more in Morning Squawk

Today 8:07 EDT

Novo Nordisk’s Wegovy pill head start forces investors to rethink Eli Lilly's GLP-1 dominance

May 04, 2026

'Bubble effect': Weight loss drug fueled growth is putting the pharma sector at risk, report finds

May 04, 2026

Weight loss and hair loss: The growing hair treatment market from GLP-1s

May 02, 2026

Apple earnings, DHS shutdown, 'Ozempic breath' and more in Morning Squawk

May 01, 2026

Healthy Returns: Eli Lilly’s chief scientific officer breaks down the latest obesity pill data

August 26, 2025

Trump fires Fed's Cook, Musk sues Apple and OpenAI, Netflix's theatrical run and more in Morning Squawk

August 26, 2025

Eli Lilly’s weight loss pill orforglipron clears its latest trial, paving way for approval

August 26, 2025

A world on weight loss drugs: How GLP-1s are reshaping the economy

August 26, 2025

Eli Lilly's obesity pill remains a viable rival to Novo's oral Wegovy despite data that underwhelmed investors

August 24, 2025

CNBC's UK Exchange newsletter: The price is REIT

August 20, 2025

FDA approves first-ever glucose monitoring system for weight loss from Signos

August 20, 2025

Viking Therapeutics shares fall more than 30% on disappointing obesity pill trial data

August 19, 2025

Novo Nordisk offers diabetes drug Ozempic for less than half the price for cash-paying U.S. patients

August 18, 2025

'Don't quit the market' when it's frothy, says Jim Cramer. Here's why

August 14, 2025

Eli Lilly hikes price of diabetes drug Mounjaro in UK as Trump pressures pharma to align drug costs

August 14, 2025

Cramer's Lightning Round: Affirm is a buy

August 11, 2025

5 things to know before the Thursday open: Chip tariffs | Cook's White House visit | Wall Street's fashionista

August 07, 2025

Eli Lilly hikes 2025 outlook, tops quarterly estimates as Mounjaro, Zepbound sales soar

August 07, 2025

Eli Lilly's obesity pill led to more than 12% weight loss in closely watched late-stage trial, paving way for approval

August 07, 2025

Healthy Returns: Medicare, Medicaid will reportedly pilot covering obesity drugs – a potential win for drugmakers

August 05, 2025

5 things to know before the Monday open: Berkshire's tariff fears | Ethereum turns 10 | Restaurants embrace spicy

August 04, 2025

Cramer's week ahead: Earnings from Palantir, Berkshire Hathaway, Disney and McDonald's

August 01, 2025

Trump's drug price ultimatum sets pharma firms scrambling

August 01, 2025

Eli Lilly’s Mounjaro shows heart health benefits in head-to-head trial with older diabetes drug Trulicity

July 31, 2025

Trump's pharmaceutical tariffs could affect some drugmakers more than others

July 29, 2025

Weight loss drugs could be a gamechanger for women with a common hormonal disorder

July 20, 2025

Healthy Returns: Chinese obesity drug emerges as a potential rival to Eli Lilly’s Zepbound

July 16, 2025

Cramer's Lightning Round: Rocket Lab is a buy

July 11, 2025

Trump's 200% tariff threat leaves pharma firms scrambling with scenario planning

July 11, 2025

< Previous 1 2 3 4 5 6 7 8 9

...

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.